OSE Immunotherapeutics SA
PAR:OSE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OSE Immunotherapeutics SA
PAR:OSE
|
FR |
|
Banco Santander SA
OTC:BCDRF
|
ES |
|
Soltec Power Holdings SA
MAD:SOL
|
ES |
|
P
|
Petrovietnam Low Pressure Gas Distribution JSC
VN:PGD
|
VN |
|
H
|
Hanryu Holdings Inc
NASDAQ:HRYU
|
KR |
|
Polyplex Corp Ltd
NSE:POLYPLEX
|
IN |
|
B
|
Bank of the Philippine Islands
XPHS:BPI
|
PH |
|
St Barbara Ltd
ASX:SBM
|
AU |
|
Blue Hat Interactive Entertainment Technology
NASDAQ:BHAT
|
CN |
|
Fintech Select Ltd
XTSX:FTEC
|
CA |
|
W
|
WHA Corporation PCL
SET:WHA
|
TH |
|
Sun Hung Kai & Co Ltd
HKEX:86
|
HK |
|
C
|
CaNickel Mining Ltd
OTC:CMLGF
|
CA |
|
Vox Valor Capital Ltd
LSE:VOX
|
MY |
|
Macnica Holdings Inc
OTC:MCNCF
|
JP |
|
Cheil Worldwide Inc
KRX:030000
|
KR |
|
G
|
General Electric Co
SIX:GE
|
US |
|
180 Life Sciences Corp
NASDAQ:ATNF
|
US |
|
M
|
Mobil'nye Telesistemy PAO
MOEX:MTSS
|
RU |
Wall Street
Price Targets
OSE Price Targets Summary
OSE Immunotherapeutics SA
According to Wall Street analysts, the average 1-year price target for
OSE
is 15.164 EUR
with a low forecast of 10.706 EUR and a high forecast of 22.05 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is OSE's stock price target?
Price Target
15.164
EUR
According to Wall Street analysts, the average 1-year price target for
OSE
is 15.164 EUR
with a low forecast of 10.706 EUR and a high forecast of 22.05 EUR.
What is OSE Immunotherapeutics SA's Revenue forecast?
Projected CAGR
-41%
The
compound annual growth rate
of OSE Immunotherapeutics SA's revenue for the next 3 years is
-41%.
